Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
News and Views

Pharmaceutical Technology


Agreements

IPR to Service Manesty Machines

Manesty (Fairfield, NJ, http://www.manesty.com/) announced that IPR Inc. (Bartlett, IL, http://www.iprinc.net/) will undertake all original equipment manufacturer (OEM) service work for Manesty's tablet presses and coaters in North America. IPR has experience servicing, repairing, and rebuilding Manesty tablet presses to clients' standards. Through IPR, Manesty will offer direct OEM service to all its North American customers.

Acquisitions

GE Acquires Wave Biotech

GE Healthcare (Chalfont St.Giles, UK, http://www.gehealthcare.com/) acquired Wave Biotech (Somerset, NJ, http://www.wavebiotech.com/), a supplier of disposable manufacturing technologies for the biopharmaceutical industry. The acquisition includes Wave Biotech's subsidiary, Wave Europe, and will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as antibodies and vaccines. Financial terms were not disclosed.

Bosch to Buy Pharmatec

The Bosch Group (Stuttgart, Germany, http://www.bosch.com/) plans to acquire Pharmatec GmbH (Dresden, Germany, http://www.pharmatec.de/), from Fresenius ProServe GmbH. The transaction will include Pharmatec's subsidiary Schoeller-Bleckmann Medizintechnik Ges.m.b.H, headquartered in Ternitz, Austria.

Bosch develops and manufactures process and packaging machinery for the pharmaceutical industries. Pharmatec focuses on hygienic and aseptic process technologies for the pharmaceutical and biotechnology industries.The purchase price was not disclosed, and the transaction is subject to approval by antitrust authorities.

People

AdvantaPure Names Director of Software Solutions

AdvantaPure (Southampton, PA, http://www.advantapure.com/) promoted Jeffrey D. Johnson to the new position of director of software solutions. Johnson's focus will be on AdvantaPure's line of radio-frequency identification (RFID) tracking products, including "GammaTag," the company's gamma-sterilizable RFID tag. His new duties include developing, installing, and supporting the company's RFID products.

Johnson previously was Advantapure's network administrator. He joined NewAge Industries, AdvantaPure's parent company, in 1990 as a sales representative.

IPS Announces Appointments

Integrated Project Services (IPS, Lafayette Hill, PA, http://www.ipsdb.com/), an engineering firm serving the pharmaceutical and biotechnology industries, appointed Eugene K.Martini senior director, projectdelivery operations. In this role, Martini will oversee the daily operations of that division.He has been involved with manufacturing and development projects regulated by the US Food and Drug Administration for the past 15 years. Martini recently worked at CDI Corporation as director of project management.

IPS also appointed David J. Brown director, project services. Brown will lead the project-services and project-controls teams to develop solutions to support client projects and business objectives. He will also implement various project-controls functions such as estimating, planning, cost control, change management, progress measurement, risk management, and cashflow projections for pharmaceutical and biopharmaceutical clients.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
9%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
Source: Pharmaceutical Technology,
Click here